Results 231 to 240 of about 70,938 (290)

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis. [PDF]

open access: yesInt J Mol Sci
Costa-Frossard L   +22 more
europepmc   +1 more source

Plasma Glial Fibrillary Acidic Protein Correlates With Brain Metal Burden in Wilson's Disease. [PDF]

open access: yesAnn Clin Transl Neurol
Fan SP   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy